Drug intelligence / Profile preview

Yimuan Gong Capsule

Development stage: Unknown
Lead developer: Yabao Pharmaceutical
Administration: Oral

Overview

Yimuan Gong Capsule is a Traditional Chinese Medicine (TCM) developed by Shanxi Yabao Pharmaceutical Group for the management of uterine bleeding following medical abortion. The formulation is designed to promote uterine involution, reduce the volume of vaginal bleeding, and shorten the duration of bleeding after the use of medical abortifacients. It typically incorporates herbal components known in TCM for their blood-activating and stasis-resolving properties, such as Motherwort (Leonurus japonicus). Clinical evaluation has included randomized, double-blind, phase 2 trials in China to assess its efficacy and safety compared to placebo in reducing post-abortion uterine bleeding.

Brand names: Yimuan Gong Capsule
Other names: Yimuan Gong Jiaonang

Beyond the preview

Go deeper on Yimuan Gong Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yimuan Gong Capsule.

Explore the full profile